Noetic Psychedelic Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Noetic psychedelic fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Noetic Psychedelic Fund Today - Breaking & Trending Today

Gilgamesh Pharmaceuticals Raises $27M In Series A With Prime Movers Lab


Gilgamesh Pharmaceuticals, a biotechnology company that uses psychedelic-related drugs to treat neuropsychiatric disorders, reported Thursday it has raised $27 million in a Series A funding round led by Prime Movers Lab.
Other investors involved in the round included the Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund and Palo Santo Investors.
Prime Movers Lab, a partnership that invests in breakthrough scientific startups, is known for raising funds for inventors in energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture.
With the newly raised capital, New York-based Gilgamesh plans to add more members to its team, including a COO, head of R&D and CBO. It will also work on advancing its programs toward clinical candidate selection and broadening its IP portfolio. ....

Amy Kruse , Jonathan Sporn , Jeff Witkin , Mike Cunningham , Andrew Kruegel , Noetic Psychedelic Fund , Movers Lab , Gilgamesh Pharmaceuticals , Prime Movers , Gron Ventures , Palo Santo , New York Based Gilgamesh , Prime Movers Lab , Dalibor Sames , ஆமி க்ரூஸ் , ஜொனாதன் ச்போர்ன் , மைக் கன்னிங்ஹாம் , நோெதிக் சைகடெலிக் நிதி , மூவர்ஸ் ஆய்வகம் , ப்ரைம் மூவர்ஸ் , பாலோ சாண்டோ , ப்ரைம் மூவர்ஸ் ஆய்வகம் ,

Noetic Fund II LP: Noetic Launches Second Fund to Invest in Emergent Psychedelic Medicine Sector


Noetic Fund II LP: Noetic Launches Second Fund to Invest in Emergent Psychedelic Medicine Sector
Having successfully launched one of the first funds operating in the nascent psychedelic medicine space, Toronto-based venture capital firm Noetic is now launching a second, larger Fund.
TORONTO, ON / ACCESSWIRE / March 4, 2021 / The Noetic Funds, founded by the team at Grey House Partners GP Inc., has announced the launch of Noetic Fund II LP ( Fund II ), a venture capital fund that is seeking to raise a minimum of $200mm to invest in early-stage psychedelic and Central Nervous System focused companies addressing global ailments such as mental health conditions, substance use disorders and distinct inflammatory related ailments. The team will build on its investment thesis validated in Noetic Psychedelic Fund LP ( Fund I ), which has provided exceptional returns to date. ....

City Of , United Kingdom , Beckley Psytech , Josh Hardman , Saad Shah , Johns Hopkins , Warren Wright , Michael Franks , Sheppard Pratt , Grey House Partners Gp Inc , University Of Oxford , Noetic Fund , Noetic Fund Ii Lp , Imperial College London , Health Canada , Noetic Psychedelic Fund Lp , Max Planck Institute , Grey House Partners , Central Nervous System , Noetic Psychedelic Fund , Mount Sinai , Breakthrough Therapy , Sa Ad Shah , Managing Partner , Apollo Neuroscience , Bexson Biomedical ,